Skip to content

Pulsed Radiofrequency Therapy vs Canal Adductor Blockade in Knee Osteoarthritis

Comparison of the Effectiveness of Pulsed Radiofrequency Therapy and Canal Adductor Blockade for Chronic Pain and Functioning in Knee Osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05962463
Enrollment
128
Registered
2023-07-27
Start date
2024-10-09
Completion date
2025-06-30
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

Adductor canal blockade, Radiofrequency therapy

Brief summary

This study is intended to prove the efficacy and safety of ultrasound-guided pulsed radiofrequency therapy on adductor canal nerves by patients with Knee osteoarthritis.

Detailed description

Knee osteoarthritis is a serious epidemiologic problem. Non-surgical methods are shown limited efficacy in relieving chronic knee pain in patients in advanced stages of knee osteoarthritis. The knee prosthesis is a successful treatment for many patients with advanced knee osteoarthritis. Still, there are important numbers of patients, which are not appropriate candidates for such surgery treatment or refused surgery for any reason. For them, any treatment which could relieve pain in their knee would have a good impact on their quality of life. Interventions like adductor canal block(ACB) and pulsed radiofrequency therapy (PRF) have demonstrated good results. In this study, investigators compare the effectiveness of these two methods. Official approval from the ethics committee of the Republic of Slovenia was obtained for this study. After being informed about the research and potential risks, all patients giving written informed consent will undergo an orthopedic examination and those with a confirmed diagnosis of knee osteoarthritis that lasted more than 6 months will be included in the study. All participants were randomly divided into two groups. Participants in the first group receive single shot ACB and participants in the second group receive PRF therapy at the same point. Before starting all patients filled the Knee injury and osteoarthritis outcome(KOOS) form and estimated the maximal and minimal intensity of pain in the knee. They repeat self-assessment of pain, in the same manner, using 11 points numeric rating score(NRS) 1 month, 3, and six months after the blockade or PRF therapy. Measurement of maximum voluntary isometric contraction of the quadriceps muscle (MVIC), time up and go test(TUG), and 30s stand-up chair test are performed by a physiotherapist before a block of adductor canal on both legs,1 hour, 1 month, 3 months and 6 months after a block or PRF therapy.The adductor canal blockl is performed by the same trained anesthesiologist at the proximal part of the leg using 14 ml of Levobupivacaine and 100 mcg of Clonidine mixed in the same syringeAfterof the study participants filled the Knee injury and osteoarthritis outcome(KOOS) form once again.

Interventions

PROCEDURECanal adductor blockade

The same experienced anesthesiologist has performed all blocks. Always after surgical cleaning of the anteromedial thigh, all participants in this group received single shot ultrasound guided canal adductor blockade. After the blockade, all participants were monitored in our ambulance for the next hour.

PROCEDURECanal adductor pulsed radio-frequency therapy

The same experienced anesthesiologist has performed all PRF therapy After surgical cleaning of the anteromedial thigh, all participants in this group received ultrasound-guided pulsed radiofrequency therapy. We've previously scanned the adductor canal and chose the middle of the canal as the entry point of the RF 10 cm needle with a 1 cm free tip. After sensory and motor checking all patients have gotten 6 minutes of therapy divided into 3 sequences of 2 minutes of 50 V current and 42ºC. After the treatment, all participants were monitored in our ambulance for the next hour.

Sponsors

University Medical Centre Ljubljana
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Diagnose of the Knee osteoarthritis confirmed by orthopedic examination * K-L grades 3 and 4 * A sufficient level of education to understand study procedures * Be able to communicate with site personnel * Age \>45 years

Exclusion criteria

: * Any cardiovascular, hepatic, or renal conditions that would compromise participation, in the opinion of the investigator * Severe neurologic conditions interfere with a knee condition * Narcotic dependent (opioid intake of more than 3 months and more than 30 mg of daily oral morphine equivalents) * Coexisting severe hematological disorder or deranged coagulation parameters * Psychiatric illnesses * Allergy to any of the drugs used in the study * Infection or malignancy at the site of the block * Any active systemic infection * Implanted electronic devices like spinal cord stimulators, cardiac pacemakers or similar

Design outcomes

Primary

MeasureTime frameDescription
Pain intensityBaseline ,1 hour,1 month, 3 month and 6 monthsChange From Baseline in Maximal and minimal Pain on the 11-point Numeric rating score Pain Scale (NRS 0-11) ;Numeric 11-point rating score is widely accepted self-reported score for measurement of chronic and acute pain in researches.Possible scores range are between 0-free of pain and 10-the worst imaginable pain.
KOOSBaseline ,1 hour,1 month, 3 month and 6 monthsThe Knee injury and osteoarthritis outcome(KOOS) score change in percentage from baseline and 1 month following adductor canal block \[ Time Frame: Baseline and 1 month following adductor canal block \] KOOS is valid,reliable outcome measure in patients with knee osteoarthritis. usually used following knee surgery.This method is recognised as useful also in other and nonsurgical knee treatment.Shortened version widely used in North America is western Ontario and McMaster Universities Index(WOMAC)

Secondary

MeasureTime frameDescription
Satisfaction of patientBaseline ,1 hour,1 month, 3 month and 6 monthsWe determine whether the patient is satisfied with the result of treatment by asking the following question: what is the least amount of success that the treatment would have to achieve by the end of the study and/or treatment for the patient to conclude that the treatment was worth it and the patient is satisfied? The patient is asked to describe the minimum goal to be satisfied with the treatment in her own words, such as: 50% reduction in pain, to go to the store without assistance, to use only one cane, to not wake up with pain, to perform regular housekeeping duties at home with minimal breaks, to walk a certain distance, or to play tennis. At the end of the study the patient indicates whether that goal was achieved with a yes or no answer.
Maximum voluntary isometric contraction of quadriceps muscle (MVIC)Baseline ,1 hour,1 month, 3 month and 6 monthsMaximum voluntary isometric contraction of quadriceps muscle (MVIC) measured by handheld dynamometer \] This method is used to check impact of block on contraction of quadriceps muscle.
30 seconds stand up chair test (30 s SCT)Baseline ,1 hour,1 month, 3 month and 6 monthsIn the 30 s CST, number of times the participant rises from a chair in 30 s is counted.
Range of knee motion (ROM)Baseline ,1 hour,1 month, 3 month and 6 monthsPassive knee joint ROM of extension and flexion was measured in the control and blocked leg in the supine position using a goniometer.
Timed up to go test (TUG)Baseline ,1 hour,1 month, 3 month and 6 monthsTime that patient need to stand up from a standard height armchair,walk 3 meters,go back to the chair and takes a seat.Used to assess a patients balance,risk of falling and global mobility

Countries

Slovenia

Contacts

Primary ContactMensur Salihovic, MD
mensur.salihovic@kclj.si+38640208892
Backup ContactMensur Salihovic
mensur.salihovic@kclj.si+38640208892

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026